Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Updated advice on lactating cow intramammary antibiotics
The VMD was informed of supply problems with certain lactating cow antibiotics earlier this year.

Multiject IMM Intramammary Suspension will arrive January 2021.

The Veterinary Medicines Directorate (VMD) has updated its advice on the availability of lactating cow intramammary antibiotics.

Earlier this year, the VMD were informed by Marketing Authorisation Holders (MAHs) of supply problems with certain lactating cow intramammary antibiotics.

On Tuesday (18 August) the list of anticipated resolution dates was updated. Combiclav Intramammary Suspension for Lactating Cows is now expected November 2020 while Multiject IMM Intramammary Suspension will arrive January 2021.

The full list is as follows:

Product Anticipated Resolution Date
Synulox Lactating Cow Intramammary Suspension (42058/4143) October-December 2020
Tetra-Delta Intramammary Suspension (42058/4152) October-December 2020
Ubro Yellow Milking Cow Intramammary Suspension (08327/4305) Product discontinued – no return date
Multiject IMM Intramammary Suspension (02000/4062) January 2021
Albiotic 330mg/100mg Intramammary Solution (30282/4035)  End of July 2020
Mastiplan LC, 300mg/20mg Intramammary Suspension (01708/4534)  End of June 2020
Cobactan MC Intramammary Suspension for Lactating Cows (42810/4000 End of June 2020
Combiclav Intramammary Suspension for Lactating Cows (02000/4424)  November 2020

The following lactating cow intramammary products have been reported as available for veterinary surgeons to purchase:

Ubropen 600 mg Intramammary Suspension for Lactating Cows (42810/4000)
Ubrolexin Intramammary Suspension for Lactating Dairy Cows (08327/4306)
Procapen Injector 3g intramammary suspension for cattle (24745/4023)
Orbenin L.A. 200mg Intramammary Suspension (42058/4090)
Pathocef 250mg Intramammary Suspension (42058/4094)*
Cefimam LC, 75 mg Intramammary
Pathocef 250mg Intramammary Suspension (42058/4094)*
Cefimam LC, 75 mg Intramammary Ointment for Lactating Cows (02000/4387)

Further details on the supply situation for individual UK-authorised product can be obtained through the MAH or a wholesale dealer.

 

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.